Literature DB >> 1234096

Studies on biliary bile acid metabolism in hepato-biliary diseases.

T Harada.   

Abstract

Biliary bile acid have been analyzed in patients with various hepato-biliary diseases by thin-layer chromatography, and divided into 4 types of glycine- and taurine-conjugates. The composition of biliary bile acid was different according to the hepatic impairement, and the ratio of glycine-conjugate to taurine-conjugate was decreased in chronic liver diseases. The G/T ratio was 1.49 +/- 0.36 in the control group, but was 0.96 +/- 0.18 in severe liver cirrhosis, and 1.38 +/- 0.44 in chronic active hepatitis. In acute hepatitis, the G/T ratio was low on the initial stage of the diseases, and returned to a normal range upon recovery. There was also a dicrease in the ratio of dihydroxycholic to cholic acid of biliary bile acid in patients with chronic liver diseases. In conclusion, the measurement of bile acid in bile has a diagnostic value for chronic hepatic impairement.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234096     DOI: 10.1007/bf02774847

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  13 in total

1.  Bile acids in the serum of jaundiced patients.

Authors:  J B CAREY
Journal:  Gastroenterology       Date:  1961-09       Impact factor: 22.682

2.  Serum-bile-acid levels in liver disease.

Authors:  E C OSBORN; I D WOOTTON; L da SILVA; S SHERLOCK
Journal:  Lancet       Date:  1959-12-12       Impact factor: 79.321

3.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

4.  Blood cholates in normal subjects and in liver disease.

Authors:  S SHERLOCK; V WALSHE
Journal:  Clin Sci       Date:  1948-02-16       Impact factor: 6.124

5.  [Blood biliary acids in hepatology. I. Introduction to a study covering 195 patients: review of acquired data, details on the analytical method utilized].

Authors:  M Rautureau; B Chevrel; J Caroli
Journal:  Rev Med Chir Mal Foie       Date:  1967 Sep-Oct

6.  Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.

Authors:  I Makino; S Nakagawa; K Mashimo
Journal:  Gastroenterology       Date:  1969-06       Impact factor: 22.682

7.  Bile acid content of human serum. I. Serum bile acids in patients with hepatic disease.

Authors:  D RUDMAN; F E KENDALL
Journal:  J Clin Invest       Date:  1957-04       Impact factor: 14.808

8.  Abnormal metabolism of secondary bile acids in patients with cirrhosis.

Authors:  Z R Vlahcevic; I Buhac; C C Bell; L Swell
Journal:  Gut       Date:  1970-05       Impact factor: 23.059

9.  Cholic acid synthesis as an index of the severity of liver disease in man.

Authors:  W C McCormick; C C Bell; L Swell; Z R Vlahcevic
Journal:  Gut       Date:  1973-11       Impact factor: 23.059

10.  Serum bile acids in liver disease.

Authors:  G Neale; B Lewis; V Weaver; D Panveliwalla
Journal:  Gut       Date:  1971-02       Impact factor: 23.059

View more
  1 in total

1.  Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage.

Authors:  J E Edwards; C LaCerte; T Peyret; N H Gosselin; J F Marier; A F Hofmann; D Shapiro
Journal:  Clin Transl Sci       Date:  2016-10-15       Impact factor: 4.689

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.